Adaptimmune Therapeutics (ADAP) Gets a Buy from Scotiabank
Scotiabank analyst George Farmer maintained a Buy rating on Adaptimmune Therapeutics (ADAP – Research Report) today and set a price target of ...
Stifel Nicolaus Reaffirms Their Buy Rating on Knight Therapeutics (KHTRF)
In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Knight Therapeutics (KHTRF – Research Report), with ...
BioPharma Dive12h
Character Biosciences raises $93M with an eye on vision loss drugs
The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...